
Bristol-Myers Squibb and European healthcare fund Life Sciences Partners are forming a strategic collaboration to identify breakthrough technologies. The companies …

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …
Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

